Furthermore, the IPA® suggested inhibition of upstream regulators such as PPARγ and PPARα transcription factors (z-score < −3.1) and anti-inflammatory proteins CD28, CD3, and NFE2L2 (z-score < −3.9) (Table 3) for HTN-T2DM hearts. Here, NFE2L2 is linked to type 2 diabetes mellitus.